AB1074
Anti-Influenza A Antibody
Chemicon®, from goat
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
polyclonal
Species reactivity:
human
Application:
ELISA
immunofluorescence
immunohistochemistry
western blot
immunofluorescence
immunohistochemistry
western blot
Technique(s):
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
Citations:
29
Product Name
Anti-Influenza A Antibody, Chemicon®, from goat
biological source
goat
antibody form
purified immunoglobulin
clone
polyclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
shipped in
wet ice
Quality Level
Analysis Note
Control
Influenza Control Slides, Catalogue Number 5010-5
Influenza Control Slides, Catalogue Number 5010-5
Application
Anti-Influenza A Antibody is an antibody against Influenza A for use in ELISA, IF, IH & WB.
Applications include ELISA, fluorescence microscopy, immunoblotting; unboiled samples in 1mM DTT and 2% SDS only and immunohistochemistry. Final working dilutions must be determined by end user.
Titer: 1:1,000 by indirect immunofluorescence. (1:2,500 by hemagglutination inhibition.)
Titer: 1:1,000 by indirect immunofluorescence. (1:2,500 by hemagglutination inhibition.)
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
Biochem/physiol Actions
Specific for Influenza A by IHA. Recognizes H1N1 and H3N2 and probably other Flu A strains. Non reactive with HEp-2 cells. May react with chicken cellular proteins. Does not react with Influenza B, RSV, Parainfluenza 1/2/3 or Adenovirus.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Influenza A-USSR (H1N1).
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Format: Purified
Protein A Purified goat immunoglobulin in PBS (0.01 M, pH 7.2) with 0.1% sodium azide as a preservative.
Protein A purified
Preparation Note
Maintain at +2–8°C for 3 months or at -20°C in aliquots for up to 12 months after date of receipt. Avoid repeated freeze/thaw cycles.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Listings
Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.
AB1074:
jan
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
H4N8 subtype avian influenza virus isolated from shorebirds contains a unique PB1 gene and causes severe respiratory disease in mice.
Bui, VN; Ogawa, H; Xininigen, ; Karibe, K; Matsuo, K; Awad, SS; Minoungou, GL; Yoden et al.
Virology null
Mari Numata et al.
The Journal of biological chemistry, 295(6), 1704-1715 (2019-12-29)
The influenza A (H1N1)pdm09 outbreak in 2009 exemplified the problems accompanying the emergence of novel influenza A virus (IAV) strains and their unanticipated virulence in populations with no pre-existing immunity. Neuraminidase inhibitors (NAIs) are currently the drugs of choice for
Chih-Heng Huang et al.
The Journal of infectious diseases, 208(11), 1898-1905 (2013-08-01)
Reassortment within polymerase genes causes changes in the pathogenicity of influenza A viruses. We previously reported that the 2009 pH1N1 PA enhanced the pathogenicity of seasonal H1N1. We examined the effects of the PA gene from the HPAI H5N1 following
Xiang Xu et al.
PloS one, 11(10), e0164501-e0164501 (2016-10-08)
Host-derived proteases can augment or help to clear infections. This dichotomy is exemplified by cathepsin L (CTSL), which helps Hendra virus and SARS coronavirus to invade cells, but is essential for survival in mice with mycoplasma pneumonia. The present study
Hao Chen et al.
Virology journal, 14(1), 242-242 (2017-12-24)
Numerous toxicological studies have focused on injury caused by exposure to single types of nanoparticles, but few have investigated how such exposures impact a host's immune response to pathogen challenge. Few studies have shown that nanoparticles can alter a host's
Global Trade Item Number
| SKU | GTIN |
|---|---|
| AB1074 | 04053252513664 |
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service